Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation

Circulation Research

Volumn 75, Issue 1, 1994, Pages 41-54

  Pauly, Rebecca R ^a   Passaniti, Antonino ^a   Bilato, Claudio ^a   Monticone, Robert ^a   Cheng, Linda ^a   Papadopoulos, Nickolas ^a   Gluzband, Yehezkiel A ^a   Smith, Lori ^a   Weinstein, Craig ^a   Lakatta, Edward G ^a   Crow, Michael T ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

basement membrane; chemotaxis; extracellular matrix; matrix metalloproteinases; smooth muscle cells

Indexed keywords

COLLAGENASE; GELATINASE; STROMELYSIN;

ANIMAL CELL; ARTICLE; BASEMENT MEMBRANE; CELL DIFFERENTIATION; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT; RNA ANALYSIS; TUNICA MEDIA; VASCULAR SMOOTH MUSCLE;

EID: 0028338823     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.75.1.41     Document Type: Article

References (59)

1. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med. 1986;314:488-500.
2. McBride W, Lange RA, Hillis LD. Restenosis after successful coronary angioplasty. N Engl J Med. 1988;318:1734-1737.
3. Liu MW, Roubin GS, King SB. Restenosis after coronary angioplasty. Circulation. 1989;79:1374-1387.
4. Chamley-Campbell JH, Campbell GR. What controls smooth muscle phenotype? Atherosclerosis. 1981;40:347-357.
5. Ross R. Polypeptide growth factors and atherosclerosis. Trends Cardiovasc Med. 1991;1:277-282.
6. Bowen-Pope DF, Ross R, Seifert RA. Locally acting growth factors for vascular smooth muscle cells: endogenous synthesis and release from platelets. Circulation. 1985;72:735-740.
7. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature. 1993;362:801-809.
8. Grotendorst GR, Seppa HEJ, Kleinman HK, Martin GR. Attachment of smooth muscle cells to collagen and their migration toward platelet-derived growth factor. Proc Natl Acad Sci U S A. 1981;78:3669-3672.
9. Bell L, Madri JA. Effect of platelet factors on migration of cultured bovine aortic endothelial and smooth muscle cells. Circ Res. 1989; 65:1057-1065.
10. Ferns GAA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science. 1991;253: 1129-1132.
11. Fingerle J, Johnson R, Clowes AW, Majesky MW, Reidy MA. Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery. Proc Natl Acad Sci U S A. 1989;86:8412-8416.
12. Jawien A, Bowen-Pope DF, Linder V, Schwartz SM, Clowes AW. Platelet-derived growth factor promotes smooth muscle migration and intimai thickening in a rat model of balloon angioplasty. J Clin Invest. 1992;89:507-511.
13. Carey DJ. Control of growth and differentiation of vascular cells by extracellular matrix proteins. Annu Rev Physiol. 1991;53:161-177.
14. Sperti G, van Leeuwen RTJ, Quax PHA, Maseri A, Kluft C. Cultured rat aortic vascular smooth muscle cells digest naturally produced extracellular matrix. Circ Res. 1992;71:385-392.
15. Wight TN, Hascall VC. Proteoglycans in primate arteries, III: characterization of the proteoglycans synthesized by arterial smooth muscle cells in culture. J Cell Biol. 1983;96:167-176.
16. Liotta LA, Steeg PA, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell. 1991;64:327-336.
17. Stetler-Stevenson WG. Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev. 1990;9:289-303.
18. Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L. Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res. 1985;44:139-266.
19. Mignatti P, Robbins E, Rifkin DB. Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell. 1986;47:487-498.
20. Booyse F, Scheinbuks M, Radek J, Osikowicz G, Feder S, Quarfoot AJ. Immunological identification and comparison of plasminogen activator forms in cultured normal human endothelial and smooth muscle cells. Thromb Res. 1981;24:495-504.
21. Clowes AW, Clowes MM, Au YPT, Reidy MA, Belin D. Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Circ Res. 1990;67:61-67.
22. Shapiro SD, Griffin GL, Gilbert DJ, Jenkins NA, Copeland NG, Welgus HG, Senior RM, Ley TJ. Molecular cloning, chromosomal localization, and bacterial expression of a murine macrophage metalloelastase. J Biol Chem. 1992;267:4664-4671.
23. Yanagi H, Sasaguri Y, Sugama K, Morimatsu M, Nagase H. Production of tissue collagenase (matrix metalloproteinase 1) by human aortic smooth muscle cells in response to platelet-derived growth factor. Atherosclerosis. 1991;91:207-216.
24. Matrisian L. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 1990;6:121-125.
25. Pauly RR, Passaniti A, Crow M, Kinsella JL, Papdopoulos N, Monticone R, Lakatta EG, Martin GR. Experimental models that mimic the differentiation and dedifferentiation of vascular cells. Circulation. 1992;86(suppl III):III-68-III-73.
26. Smith JB, Brock TA. Analysis of angiotensin-stimulated sodium transport in cultured smooth muscle cells from rat aorta. J Cell Physiol. 1983;114:284-290.
27. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEwan RN. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 1987;47: 3239-3245.
28. Kleinman HK, McGarvey ML, Hassell JR, Starr VL, Cannon FB, Laurie GW, Martin GR. Basement membrane complexes with biological activity. Biochemistry. 1986;25:312-318.
29. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
30. Melchiori A, Albini A, Ray JM, Stetler-Stevenson WG. Inhibition of tumor cell invasion by a highly conserved peptide sequence from the matrix metalloproteinase enzyme prosegment. Cancer Res. 1992;52:2353-2356.
31. Van Wart HE, Birkedal-Hansen H. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci U S A. 1990;87:5578-5582.
32. Darlak K, Miller RB, Stack MS, Spatola AF, Gray RD. Thiol-based inhibitors of mammalian collagenase. J Biol Chem. 1990;265:5199-5205.
33. Heussen C, Dowdle EB. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem. 1980;102:196-202.
34. Bickett DM, Green MD, Berman J, Dezube M, Howe AS, Brown PJ, Roth JT, McGeehan GM. A high throughput fluorogenic substrate for intersitital collagenase (MMP-1) and gelatinase (MMP-9). Anal Biochem. 1993;212:58-64.
35. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979;18:5294-5299.
36. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1989.
37. Church GM, Gilbert W. Genomic sequencing. Proc Natl Acad Sci U S A. 1984;81:1991-1995.
38. Fort PH, Marty L, Piechaczyk M, El Sabrouty S, Dani CH, Jeanteur PH, Blanchard JM. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 1985;13: 1431-1442.
39. McHugh KM, Lessard JL. The nucleotide sequence of a rat vascular smooth muscle a-actin cDNA. Nucleic Acids Res. 1988; 16:167.
40. Collier IE, Wihelm SM, Eisen AZ, Marmer BL, Grant GA, Seltzer JL, Kronberger A, He C, Bauer EA, Goldberg GI. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem. 1988;263:6579-6587.
41. Gewert DR, Coulombe B, Castelino M, Skup D, Williams BRG. Characterization and expression of a murine gene homologous to human EPA/TIMP: a virus-induced gene in the mouse. EMBO J. 1987;6:651-657.
42. Stetler-Stevenson WG, Brown PD, Onisto M, Levy AT, Liotta LA. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem. 1990;265:13933-13938.
43. Breathnach R, Matrisian LM, Gesnel M-C, Staub A, Leroy P. Sequences coding for part of oncogene-induced transin are highly conserved in a related rat gene. Nucleic Acids Res. 1987;15: 1139-1151.
44. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem. 1989;264:17213-17221.
45. Quinn CO, Scott DK, Brinckerhoff CE, Matrisian LM, Jeffrey JJ, Partridge NC. Rat collagenase. J Biol Chem. 1990;265:22342-22347.
46. Feinberg A, Vogelstein B. A new technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983;132:6-13.
47. Babij P, Periasamy M. Myosin heavy chain isoform diversity in smooth muscle is produced by differential RNA processing. J Mol Biol. 1989;210:673-679.
48. Mackay AR, Gomez DE, Cottam DW, Rees RC, Nason AM, Thorgeirsson UP. Identification of the 72 kDa (MMP-2) and 92 kDa (MMP-9) gelatinase/typeIV collagenase in preparations of laminin and matrigel. Biotechniques. 1993;15:1048-1051.
49. Schwartz SM, Campbell GR, Campbell JH. Replication of smooth muscle cells in vascular disease. Circ Res. 1986;58:427-444.
50. Blank RS, Thompson MM, Owens GK. Cell cycle versus density dependence of smooth muscle alpha actin expression in cultured rat aortic smooth muscle cells. J Cell Biol. 1988;107:299-306.
51. Clowes AW, Karnovsky MJ. Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature. 1977;265: 625-626.
52. Clowes AW, Clowes MM. Kinetics of cellular proliferation after arterial injury, IV: heparin inhibits rat smooth muscle cell mitogenesis and migration. Circ Res. 1986;47:578-583.
53. Clowes AW, Clowes MM, Kirkman TR, Jackson CL, Au YPT, Kenagy R. Heparin inhibits the expression of tissue-type plasminogen activator by smooth muscle cells in injured rat carotid artery. Circ Res. 1992;70:1128-1136.
54. Librach CL, Werb Z, Fitzgerald ML, Chiu K, Corwin NM, Esteves RA, Grobelny D, Galardy R, Damsky CH, Fisher SJ. 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol. 1991;113:437-449.
55. Libby P. Human vascular smooth muscle cells: target for and source of tumor necrosis factor. J Immunol. 1989;142:100-109.
56. Loppnow H, Libby P. Functional significance of human vascular smooth muscle cell-derived interleukin 1 in paracrine and autocrine regulation pathways. Exp Cell Res. 1992;198:283-290.
57. Majesky MW, Giachelli CM, Reidy MA, Schwartz SM. Rat carotid neointimal smooth muscle cells reexpress a developmentally regulated mRNA phenotype during repair of arterial injury. Circ Res. 1992;71:759-768.
58. Goldberg GI, Marmer BL, Grant GA, Eisen AZ, Wilhelm S, He C. Human 72-kDa type IV collagenase forms a complex with a tissue inhibitor of metalloproteinase. Proc Natl Acad Sci U S A. 1989;86: 8207-8211.
59. Moses MA, Sudhalter J, Langer R. Identification of an inhibitor of neovascularization from cartilage. Science. 1990;248:1408-1410.